167300-06-3

Basic information

• Product Name: METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID
• Synonyms: METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID;4-METHYL-3-(METHOXYCARBONYL)BENZOIC ACID;METHY-2-METHYL-5-CARBOXYLICBENZOIC ACID;3-(Methoxycarbonyl)-4-Methylbenzoic acid;3-(Methoxycarbonyl)
• CAS NO: 167300-06-3
• Molecular Formula: C₁₀H₁₀O₄
• Molecular Weight: 194.18
• Mol File: 167300-06-3.mol

Chemical Properties

• Boiling Point: 349.9°Cat760mmHg
• Flash Point: 140.1°C
• Appearance: /
• Density: 1.243g/cm³
• Vapor Pressure: 1.7E-05mmHg at 25°C
• Refractive Index: 1.55
• Storage Temp.: Sealed in dry,Room Temperature
• PKA: 4.00±0.10(Predicted)
• CAS DataBase Reference: METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID(167300-06-3)
• EPA Substance Registry System: METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID(167300-06-3)

Safety Data

• Hazardous Substances Data: 167300-06-3(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID is used as a building block for the synthesis of various organic compounds, facilitating the creation of a wide range of chemical entities with diverse applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID is utilized as a key intermediate in the development of new drugs, contributing to the advancement of medicinal chemistry and the discovery of novel therapeutic agents.
Used in Biological Activity Studies:
METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID is employed in research to investigate its potential biological activities, which may include antimicrobial, antioxidant, or other beneficial properties for human health.
Used in Pharmacological Property Evaluation:
METHYL-2-METHYL-5-CARBOXYLICBENZOIC ACID is also used in pharmacological studies to assess its potential therapeutic effects and safety profile, guiding its application in the development of new medications.

InChI:InChI=1/C10H10O4/c1-6-3-4-7(9(11)12)5-8(6)10(13)14-2/h3-5H,1-2H3,(H,11,12)

Upstream product

• 67-56-1 methanol 
• 201230-82-2 carbon monoxide 
• 7697-26-9 3-bromo-4-methylbenzoic acid 
• 79-22-1 methyl chloroformate 
• 105650-34-8 5-formyl-2-methylbenzoic acid 
• 675148-96-6 methyl 5-formyl-2-methylbenzoate 

Downstream Products

• 1012342-32-3 4-methyl-isophthalic acid 1-tert-butyl ester 3-methyl ester 
• 1346607-24-6 5-{6-chloro-5-[2'-hydroxy-3'-(methyloxy)-4-biphenylyl]-2,4-dioxo-1,2,4,5-tetrahydro-3H-pyrrolo[3,2-d]pyrimidin-3-yl}-2-methylbenzoic acid 
• 1346608-07-8 ethyl 5-chloro-1-[2'-hydroxy-3'-(methyloxy)-4-biphenylyl]-3-{[({4-methyl-3-[(methyloxy)carbonyl]phenyl}amino)carbonyl]amino}-1H-pyrrole-2-carboxylate 

Relevant articles and documents

PHENYL mTORC INHIBITORS AND USES THEREOF

The present invention provides compounds, compositions thereof, and methods of using the same.

Substrates of O6-alkylguanine-DNA alkyltransferase and mutants thereof

The invention relates to compounds of formula (I′): in which A, L2, M and B are as defined in the description. These compounds are substrates of O6-alkylguanine-DNA alkyltransferase and mutants thereof.

HETEROARYL DERIVATIVES AS PROTEIN KINASE INHIBITORS

Objects of the present invention are the compounds of formula I their pharmaceutically acceptable salts, enantiomeric forms, diastereoisomers and racemates, the preparation of the above-mentioned compounds, medicaments containing them and their manufacture, as well as the use of the above-mentioned compounds in the control or prevention of illnesses such as cancer.